What is MedArbor?
MedArbor Diagnostics operates as a full-service, accredited clinical laboratory near Philadelphia, providing rapid and dependable diagnostic solutions to healthcare providers. The company offers an extensive suite of testing services, encompassing molecular diagnostics, toxicology, and wellness panels, designed to identify pathogens and the root causes of various diseases. MedArbor's services are targeted towards clinicians, healthcare providers, and long-term care facilities that require comprehensive and precise diagnostic results to support informed patient care decisions.
How much funding has MedArbor raised?
MedArbor has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in MedArbor
PPP
Public-Private Partnership
What's next for MedArbor?
With substantial backing and a focus on late-stage growth, MedArbor is poised to expand its diagnostic capabilities and market reach. The company's strategic investment signals confidence in its business model and its ability to scale operations. Future developments are likely to involve enhancing its testing portfolio, potentially integrating advanced technologies, and solidifying its partnerships with healthcare institutions to further its mission of delivering best-in-class diagnostic services.
See full MedArbor company page
